Not applicableStudy completedNCT07211451What this trial is testingAxillary Nodal Burden in HER2+ and TNBCWho this might be right forBreast Cancer Gangnam Severance Hospital 1,571
Testing effectiveness (Phase 2)Study completedNCT04150731What this trial is testing16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast CancerWho this might be right forBreast Cancer University of Aarhus 8
Testing effectiveness (Phase 2)UnknownNCT04881929What this trial is testingStudy of KN026 in Combination With Docetaxel as Neoadjuvant Therapy in HER2-positive Breast CancerWho this might be right forBreast Cancer Jiangsu Alphamab Biopharmaceuticals Co., Ltd 30
Not applicableStudy completedNCT00469339What this trial is testingRisk Communication Within Mexican-American FamiliesWho this might be right forBreast CancerDiabetesColon Cancer+1 more National Human Genome Research Institute (NHGRI) 498
Not applicableLooking for participantsNCT06994377What this trial is testingEmotional Distress in Patients With Metastatic Breast Cancer in First Line of TherapyWho this might be right forMetastatic Breast Cancer European Institute of Oncology 1,000
Not applicableNot Yet RecruitingNCT07828119What this trial is testingThe Effect of a Hybrid Approach in Breast Cancer Education on Women's Awareness, Fatalism, and Self-Compassion Levels: A Randomized Controlled TrialWho this might be right forBreast Cancer Awareness Kahramanmaras Sutcu Imam University 128
Large-scale testing (Phase 3)Looking for participantsNCT07062965What this trial is testingLearn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.Who this might be right forBreast Cancer Pfizer 400
Not applicableActive Not RecruitingNCT05488483What this trial is testingTumor Imaging With Multispectral Optoacoustic TomographyWho this might be right forBreast CancerMelanoma Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00291694What this trial is testingProtocol for Women at Increased Risk of Developing Breast CancerWho this might be right forBreast Cancer Carol Fabian, MD 72
Not applicableStudy completedNCT05000502What this trial is testingExercise, Gut Microbiome, and Breast Cancer: Increasing Reach to Underserved PopulationsWho this might be right forFemale Breast Cancer University of Alabama at Birmingham 48
Testing effectiveness (Phase 2)Looking for participantsNCT06342037What this trial is testingNOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 TrialWho this might be right forMetastatic Breast Cancer The Netherlands Cancer Institute 60
Large-scale testing (Phase 3)Looking for participantsNCT07071337What this trial is testingSKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine TherapyWho this might be right forMetastatic Breast Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 430
Not applicableStudy completedNCT01880645What this trial is testingSelective Image Guided Resection of Axillary Lymph NodesWho this might be right forBreast Cancer M.D. Anderson Cancer Center 17
Very early researchNot Yet RecruitingNCT05505812What this trial is testingStudy on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast CancerWho this might be right forBreast Cancer The Affiliated Hospital of Qingdao University 10
Not applicableEnded earlyNCT03970967What this trial is testingAlpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant MetastasesWho this might be right forBreast CarcinomaMetastatic Breast CancerInvasive Breast Cancer+1 more Alpha Tau Medical LTD. 1
Early research (Phase 1)Study completedNCT03508011What this trial is testingIMP4297 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumoursBreast CancerOvarian Cancer+1 more Impact Therapeutics, Inc. 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06639672What this trial is testingNeoadjuvant Chemotherapy + PD-1 Inhibitor+Different Radiotherapy Fractionations for HR+/HER2- Breast CancerWho this might be right forHR+HER2- Breast Cancer Lei Liu 60
Not applicableStudy completedNCT02327572What this trial is testingAge-related Changes in the Immune System and Their Impact on Elderly Breast CancerWho this might be right forBreast Cancer Universitaire Ziekenhuizen KU Leuven 60
Large-scale testing (Phase 3)Study completedNCT00003972What this trial is testingCombination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast CancerWho this might be right forBreast Cancer Fred Hutchinson Cancer Center 280
Large-scale testing (Phase 3)Ended earlyNCT06038539What this trial is testingEfficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast CancerWho this might be right forHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Biocon Biologics UK Ltd 55